- Home
- MRVI
as 07-26-2024 4:00pm EST
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 1.1B | IPO Year: | 2020 |
| Target Price: | $11.44 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.52 - $12.11 | Next Earning Date: | 08-07-2024 |
| Revenue: | $274,099,000 | Revenue Growth: | -61.81% |
| Revenue Growth (this year): | -2.85% | Revenue Growth (next year): | 9.58% |
Stock Insider Trading Activity of Maravai LifeSciences Holdings Inc. (MRVI)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| GTCR INVESTMENT XI LLC | MRVI | Director10% Owner | May 28 '24 | Sell | $9.82 | 9,940,974 | $97,570,659.81 | 20,150,005 | SEC Form 4 |
Latest Maravai LifeSciences Holdings Inc. News
MRVI Breaking Stock News: Dive into MRVI Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
MT Newswires
17 days ago
Goldman Sachs Trims Price Target on Maravai LifeSciences to $7 From $8, Maintains Neutral Rating
GlobeNewswire
24 days ago
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
Insider Monkey
a month ago
Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best
GuruFocus.com
a month ago
Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc
CNW Group
2 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Compare MRVI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MRVI Maravai LifeSciences Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.